EPISODE · Nov 6, 2024 · 23 MIN
205. Improving Mobility and Strength with the Exoband for MS Patients
from The MSing Link · host Dr. Gretchen Hawley PT, DPT, MSCS
In this episode, I chat with Dr. Panizzolo about the Exoband, an innovative assistive technology for individuals with multiple sclerosis. We discuss what the Exoband is, who it’s for, and how it enhances mobility and strength. If you’re seeking effective tools and strategies to improve your quality of life with MS, tune in to learn how the Exoband can support your journey! Dr. Panizzolo is a Professor in Biomedical Engineering and Sport Science. He completed his PhD at the University of Western Australia in Biomechanics & Motor control and was a researcher at the Biodesign Lab of Harvard University and the Wyss Institute for Biologically Inspired Engineering. After carrying out research in Canada, Australia and the United States, he founded Moveo. The company is producing ExoBand, the most lightweight wearable device ever made to help people walk better. Resources mentioned in this episode: Exoband website - https://www.moveowalks.com/ Exoband Instagram - https://www.instagram.com/moveowalks Sign up for Dr. Gretchen's email list - https://www.doctorgretchenhawley.com/EmailList Check out The MSing Link program - https://www.drgretchenhawley.com/the-msing-link-program Additional Resources: https://www.doctorgretchenhawley.com/insider Reach out to Me: [email protected] Website: www.MSingLink.com Social: ★ Facebook: https://www.facebook.com/groups/mswellness ★ Instagram: https://www.instagram.com/doctor.gretchen ★ YouTube: https://www.youtube.com/c/doctorgretchenhawley?sub_confirmation=1 → Game Changers Course: https://www.doctorgretchenhawley.com/GameChangersCourse → Total Core Program: https://www.doctorgretchenhawley.com/TotalCoreProgram → The MSing Link: https://www.doctorgretchenhawley.com/TheMSingLink
NOW PLAYING
205. Improving Mobility and Strength with the Exoband for MS Patients
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m